Abstract:Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue.Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated.Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH.Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes.Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety. Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue. Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated. Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH. Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes. Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety.

Exogenous Luteinizing Hormone Promotes Ovarian Survival and Function During Cryopreservation and Transplantation

The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone

The Revascularization and Follicular Survival of Mouse Ovarian Grafts Treated with FSH During Cryopreservation by Vitrification.

Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation

L-Proline Enhanced Whole Ovary Cryopreservation by Inhibiting Ice Crystal Growth and Reducing Oxidative Stress

Transplantation of intact rat gonads using vascular anastomosis: effects of cryopreservation, ischaemia and genotype

VEGF and Bfgf Increase Survival of Xenografted Human Ovarian Tissue in an Experimental Rabbit Model

Effects of Cryopreservation on Mouse Ovarian Tissue after Vitrification

Effects of Two Cryoprotectants on Mouse Ovarian Tissue after Vitrification

Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice.

Experimental Study on the Vitrification and Xenotransplantation of Human Ovarian Tissue

Morphology and Cell Proliferation Evaluation of Follicles from Cryopreserved Human Ovarian Tissue by Vitrifiction and Slow-cooling

Fertility restore of allotransplantation of vitrified-warmed junvenile ovaries treated with a modified vitrification solution

Modified Vitrification Method for Cryopreservation of Human Ovarian Tissues

Cryopreserved Ovarian Tissues Can Maintain A Long-Term Function after Heterotopic Autotransplantation in Rat

[Investigation of Follicular Development and Oocyte Maturation after Cryopreservation and Xenograft of Newborn Mouse Ovaries].

Effects of LH Intervention on the Expressions of Cultured Mouse Ovarian VEGF and Survivin

Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification

Ovarian function reconstruction by orthotopic transplantation of novel vitrification cryopreserved ovaries in chemotherapy-induced ovary damage rat model]

Human Ovarian Cortex Cryopreservation and Banking

Orthotopic Transplantation of Cryopreserved Mouse Ovaries and Gonadotrophin Releasing Hormone Analogues in the Restoration of Function Following Chemotherapy-Induced Ovarian Damage